Fatty acids as regulators of lipid metabolism

European Journal of Lipid Science and Technology

Volumn 102, Issue 12, 2000, Pages 746-762

  Wolfrum, Christian ^a   Spener, Friedrich ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Fatty acid binding proteins; Fatty acids; Lipid metabolism; Nuclear receptors; Regulation

Indexed keywords

RODENTIA;

EID: 0034339546     PISSN: 14387697     EISSN: None     Source Type: Journal    
DOI: 10.1002/1438-9312(200012)102:12<746::AID-EJLT746>3.0.CO;2-R     Document Type: Article

References (138)

1. L. H. Kushi, E. B. Lenart, W. C. Willett: Health implications of Mediterranean diets in light of contemporary knowledge. 2. Meat, wine, fats, and oils. Am. J. Clin. Nutr. 61 (1995) 1416S-1427S.
2. L. Lissner, B. L. Heitmann, C. Bengtsson: Population studies of diet and obesity. Br. J. Nutr. 83 (2000) S21-S24.
3. J. Auwerx: Regulation of gene expression by fatty acids and fibric acid derivatives: an integrative role for peroxisome proliferator activated receptors. The Belgian Endocrine Society Lecture 1992. Horm. Res. 38 (1992) 269-277.
4. E. Duplus, M. Glorian, C. Forest: Fatty acid regulation of gene transcription. J. Biol. Chem. 275 (2000) 30749-30752.
5. I. Niot, H. Poirier, P. Besnard: Regulation of gene expression by fatty acids: special reference to fatty acid-binding protein (FABP). Biochimie 79 (1997) 129-133.
6. D. B. Jump, S. D. Clarke: Regulation of gene expression by dietary fat. Annu. Rev. Nutr. 19 (1999) 63-90.
7. T. Lemberger, B. Desvergne, W. Wahli: Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu. Rev. Cell Dev. Biol. 12 (1996) 335-363.
8. R. T. Nolte, G. B. Wisely, S. Westin, J. E. Cobb, M. H. Lambert, R. Kurokawa, M. G. Rosenfeld, T. M. Willson, C. K. Glass, M. V. Milburn: Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 395 (1998) 137-143.
9. P. Escher, W. Wahli: Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat. Res. 448 (2000) 121-138.
10. O. Braissant, W. Wahli: Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development. Endocrinology 139 (1998) 2748-2754.
11. S. A. Kliewer, B.M. Forman, B. Blumberg, E. S. Ong, U. Borgmeyer, D. J. Mangelsdorf, K. Umesono, R. M. Evans: Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA 91 (1994) 7355-7359.
12. L. Fajas, D. Auboeuf, E. Raspe, K. Schoonjans, A. M. Lefebvre, R. Saladin, J. Najib, M. Laville, J.C. Fruchart, S. Deeb, A. Vidal-Puig, J. Flier, M. R. Briggs, B. Staels, H. Vidal, J. Auwerx: The organization, promoter analysis, and expression of the human PPARgamma gene. J. Biol. Chem. 272 (1997) 18779-18789.
13. P. Tontonoz, E. Hu, R. A. Graves, A. I. Budavari, B. M. Spiegelman: mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8 (1994) 1224-1234.
14. L. Fajas, J. C. Fruchart, J. Auwerx: PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter. FEBS Lett. 438 (1998) 55-60.
15. G. Krey, O. Braissant, F. L'Horset, E. Kalkhoven, M. Perroud, M. G. Parker, W. Wahli: Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11 (1997) 779-791.
16. B. M. Forman, J. Chen, R. M. Evans: Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc. Natl. Acad. Sci. USA 94 (1997) 4312-4317.
17. Q. Lin, S. E. Ruuska, N. S. Shaw, D. Dong, N. Noy: Ligand selectivity of the peroxisome proliferator-activated receptor alpha. Biochemistry 38 (1999) 185-190.
18. P. Ellinghaus, C. Wolfrum, G. Assmann, F. Spener, U. Seedort: Phytanic acid activates the peroxisome proliferator-activated receptor alpha (PPARalpha) in sterol carrier protein 2-/ sterol carrier protein x-deficient mice. J. Biol. Chem. 274 (1999) 2766-2772.
19. 2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83 (1995) 813-819.
20. B. Staels, K. Schoonjans, J. C. Fruchart, J. Auwerx: The effects of fibrates and thiazolidinediones on plasma triglyceride metabolism are mediated by distinct peroxisome proliferator activated receptors (PPARs). Biochimie 79 (1997) 95-99.
21. P. W. Young, D. R. Buckle, B. C. Cantello, H. Chapman, J. C. Clapham, P. J. Coyle, D. Haigh, R. M. Hindley, J. C. Holder, H. Kallender, A. J. Latter, K. W. M. Lawrie, D. Mossakowska, G. J. Murphy, L. Roxbee Cox, S. A. Smith: Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma. J. Pharmacol. Exp. Ther. 284 (1998) 751-759.
22. C. N. Palmer, C. R. Wolf: cis-parinaric acid is a ligand for the human peroxisome proliferator activated receptor gamma: development of a novel spectrophotometric assay for the discovery of PPARgamma ligands. FEBS Lett. 431 (1998) 476-480.
23. S. Y. Moya-Camarena, J. P. Vanden Heuvel, S. G. Blanchard, L. A. Leesnitzer, M. A. Belury: Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha. J. Lipid Res. 40 (1999) 1426-1433.
24. C. Wolfrum, P. Ellinghaus, M. Fobker, U. Seedorf, G. Assmann, T. Börchers, F. Spener; Phytanic acid is ligand and transcriptional activator of murine liver fatty acid binding protein. J. Lipid Res. 40 (1999) 708-714.
25. A. W. Zomer, B. van Der Burg, G. A. Jansen, R. J. Wanders, B. T. Poll-The, P. T. van Der Saag: Pristanic acid and phytanic acid. Naturally occurring ligands for the nuclear receptor peroxisome proliferator-activated receptor alpha. J. Lipid Res. 41 (2000) 1801-1807.
26. P. Tontonoz, R. A. Graves, A. I. Budavari, H. Erdjument-Bromage, M. Lui, E. Hu, P. Tempst, B. M. Spiegelman: Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha. Nucleic Acids Res. 22 (1994) 5628-5634.
27. I. Issemann, R. Prince, J. Tugwood, S. Green: A role for fatty acids and liver fatty acid binding protein in peroxisome proliferation? Biochem. Soc. Trans. 20 (1992) 824-827.
28. C. Juge-Aubry, A. Pernin, T. Favez, A. G. Burger, W. Wahli, C. A. Meier, B. Desvergne: DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5'-flanking region. J. Biol. Chem. 272 (1997) 25252-25259.
29. D. J. Peet, B. A. Janowski, D. J. Mangelsdorf: The LXRs: a new class of oxysterol receptors. Curr. Opin. Genet. Dev. 8 (1998) 571-575.
30. K. A. Tobin, H. H. Steineger, S. Alberti, O. Spydevold, J. Auwerx, J. A. Gustafsson, H. I. Nebb: Cross-talk between fatty acid and cholesterol metabolism mediated by liver X receptor-alpha. Mol. Endocrinol. 14 (2000) 741-752.
31. R. Hertz, J. Bar-Tana: Peroxisome proliferator-activated receptor (PPAR) alpha activation and its consequences in humans. Toxicol. Lett. 102-103 (1998) 85-90.
32. C. N. Palmer, M. H. Hsu, K. J. Griffin, J. L. Raucy, E. F. Johnson: Peroxisome proliferator activated receptor-alpha expression in human liver. Mol. Pharmacol. 53 (1998) 14-22.
33. J. C. Fruchart, P. Duriez, B. Staels: Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis. Curr. Opin. Lipidol. 10 (1999) 245-257.
34. W. S. Chen, K Manova, D. C. Weinstein, S. A. Duncan, A. S. Plump, V. R. Prezioso, R. F. Bachvarova, J. E. Damell, Jr.: Disruption of the HNF-4 gene, expressed in visceral endoderm, leads to cell death in embryonic ectoderm and impaired gastrulation of mouse embryos. Genes Dev. 8 (1994) 2466-2477.
35. R. Hertz, J. Magenheim, I. Berman, J. Bar-Tana: Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha. Nature 392 (1998) 512-516.
36. C. Hohoff, F. Spener: Fatty acid binding proteins and mammary-derived growth inhibitor. Fett/Lipid 100 (1998) 252-263.
37. C. Wolfrum, T. Börchers, J. C. Sacchettini, F. Spener: Binding of fatty acids and peroxisome proliferators to orthologous fatty acid binding proteins from human, murine, and bovine liver. Biochemistry 39 (2000) 1469-1474.
38. J. Thompson, N. Winter, D. Terwey, J. Bratt, L. Banaszak: The crystal structure of the liver fatty acid-binding protein. A complex with two bound oleates. J. Biol. Chem. 272 (1997) 7140-7150.
39. J. W. Lawrence, D. J. Kroll, P. I. Eacho: Ligand-dependent interaction of hepatic fatty acid-binding protein with the nucleus. J. Lipid Res. 41 (2000) 1390-1401.
40. C. Wolfrum, C. M. Borrmann, W. W. Franke, J. Gorski, F. Spener: Fatty acids and drugs interacting with FABP and PPARa in hepatocytes - a signaling path to the nucleus. Chem. Phys. Lipids 101 (1999) 149.
41. S. D. Clarke, M. K. Armstrong, D. B. Jump: Dietary polyunsaturated fats uniquely suppress rat liver fatty acid synthase and S14 mRNA content. J. Nutr. 120 (1990) 225-231.
42. S. D. Clarke, D. B. Jump: Dietary polyunsaturated fatty acid regulation of gene transcription. Annu. Rev. Nutr. 14 (1994) 83-98.
43. J. Xu, M. T. Nakamura, H. P. Cho, S. D. Clarke: Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids. A mechanism for the coordinate suppression of lipogenic genes by polyunsaturated fats. J. Biol. Chem. 274 (1999) 23577-23583.
44. B. Ren, A. P. Thelen, J. M. Peters, F. J. Gonzalez, D. B. Jump: Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor alpha. J. Biol. Chem. 272 (1997) 26827-26832.
45. H. Shimano, J. D. Horton, R. E. Hammer, I. Shimomura, M. S. Brown, J. L. Goldstein: Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J. Clin. Invest. 98 (1996) 1575-1584.
46. M. S. Brown, J. L. Goldstein: The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89 (1997) 331-340.
47. M. H. Tsai, M. Roudebush, S. Dobrowolski, C. L. Yu, J. B. Gibbs, D. W. Stacey: Ras GTPase-activating protein physically associates with mitogenically active phospholipids. Mol. Cell. Biol. 11 (1991) 2785-2793.
48. W. A. Khan, G. C. Blobe, Y. A. Hannun: Activation of protein kinase C by oleic acid. Determination and analysis of inhibition by detergent micelles and physiologic membranes: requirement for free oleate. J. Biol. Chem. 267 (1992) 3605-3612.
49. M. E. Lowe: Pancreatic triglyceride lipase and colipase: insights into dietary fat digestion. Gastroenterology 107 (1994) 1524-1536.
50. C. Ruellan, J. Moreau, M. Bouisson, A. Ribet: The Ebner glands: a pancreatic-like gland secreting an acid lipase. Secretory regulation in vitro. Int. J. Pancreatol. 3 (1988) 293-300.
51. C. Wicker, A. Puigserver: Rat pancreatic colipase mRNA: nucleotide sequence of a cDNA clone and nutritional regulation by a lipidic diet. Biochem. Biophys. Res. Commun. 167 (1990) 130-136.
52. J. E. Sabb, P. M. Godfrey, P. M. Brannon: Adaptive response of rat pancreatic lipase to dietary fat: effects of amount and type of fat. J. Nutr. 116 (1986) 892-899.
53. U. Rausch, K. Rüdiger, P. Vasiloudes, H. Kern, G. Scheele: Lipase synthesis in the rat pancreas is regulated by secretin. Pancreas 1 (1986) 522-528.
54. R. Verger, M. Aoubala, F. Carrière, S. Ransac, L. Dupuis, J. De Caro, F. Ferrato, I. Douchet, R. Laugier, A. De Caro: Regulation of lumen fat digestion: enzymic aspects. Proc. Nutr. Soc. 55 (1996) 5-18.
55. J. Gore, C. Hoinard, C. Couet: Linoleic acid uptake by isolated enterocytes: influence of alpha-linolenic acid on absorption. Lipids 29 (1994) 701-706.
56. W. Stremmel, H. E. Diede: Fatty acid uptake by human hepatoma cell lines represents a carrier-mediated uptake process. Biochim. Biophys. Acta 1013 (1989) 218-222.
57. D. Sorrentino, D. Stump, B. J. Potter, R. B. Robinson, R. White, C. L. Kiang, P. D. Berk: Oleate uptake by cardiac myocytes is carrier mediated and involves a 40-kD plasma membrane fatty acid binding protein similar to that in liver, adipose tissue, and gut. J. Clin. Invest. 82 (1988) 928-935.
58. A. Stahl, D. J. Hirsch, R. E. Gimeno, S. Punreddy, P. Ge, N. Watson, S. Patel, M. Kotler, A. Raimondi, L. A. Tartaglia, H. F. Lodish: Identification of the major intestinal fatty acid transport protein. Mol. Cell 4 (1999) 299-308.
59. T. Y. Hui, B. I. Frohnert, A. J. Smith, J. E. Schaffer, D. A. Bernlohr: Characterization of the murine fatty acid transport protein gene and its insulin response sequence. J. Biol. Chem. 273 (1998) 27420-27429.
60. K. Motojima, P. Passilly, J. M. Peters, F. J. Gonzalez, N. Latruffe: Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue-and inducer-specific manner. J. Biol. Chem. 273 (1998) 16710-16714.
61. G. Martin, K. Schoonjans, A. M. Lefebvre, B. Staels, J. Auwerx: Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators. J. Biol. Chem. 272 (1997) 28210-28217.
62. P. Besnard, I. Niot: Role of lipid-binding proteins in intestinal absorption of long-chain fatty acids. In: Fat Digestion and Absorption. Eds. A.B. Christophe & S. DeVriese, AOCS Press, Champaign IL (USA) 2000, pp. 96-118.
63. R. Brandes, R. M. Kaikaus, N. Lysenko, R. K. Ockner, N. M. Bass: Induction of fatty acid binding protein by peroxisome proliferators in primary hepatocyte cultures and its relationship to the induction of peroxisomal beta-oxidation. Biochim. Biophys. Acta 1034 (1990) 53-61.
64. H. Poirier, I. Niot, P. Degrace, M. C. Monnot, A. Bernard, P. Besnard: Fatty acid regulation of fatty acid-binding protein expression in the small intestine. Am. J. Physiol. 273 (1997) G289-G295.
65. G. V. Richieri, R. T. Ogata, A. M. Kleinfeld: Thermodynamic and kinetic properties of fatty acid interactions with rat liver fatty acid-binding protein. J. Biol. Chem. 271 (1996) 31068-31074.
66. G. V. Richieri, R. T. Ogata, A. M. Kleinfeld: Kinetics of fatty acid interactions with fatty acid binding proteins from adipocyte, heart, and intestine. J. Biol. Chem. 271 (1996) 11291-11300.
67. L. J. Baier, J. C. Sacchettini, W. C. Knowler, J. Eads, G. Paolisso, P. A. Tataranni, H. Mochizuki, P. H. Bennett, C. Bogardus, M. Prochazka: An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J. Clin. Invest. 95 (1995) 1281-1287.
68. L. J. Baier, C. Bogardus, J. C. Sacchettini: A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. J. Biol. Chem. 271 (1996) 10892-10896.
69. K. Schoonjans, M. Watanabe, H. Suzuki, A. Mahfoudi, G. Krey, W. Wahli, P. Grimaldi, B. Staels, T. Yamamoto, J. Auwerx: Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter. J. Biol. Chem. 270 (1995) 19269-19276.
70. R. K. Berge, L. Madsen, H. Vaagenes, K. J. Tronstad, M. Göttlicher, A. C. Rustan: In contrast with docosahexaenoic acid, eicosapentaenoic acid and hypolipidaemic derivatives decrease hepatic synthesis and secretion of triacylglycerol by decreased diacylglycerol acyltransferase activity and stimulation of fatty acid oxidation. Biochem. J. 343 (1999) 191-197.
71. J. R. Wetterau, D. B. Zilversmit: Localization of intracellular triacylglycerol and cholesteryl ester transfer activity in rat tissues. Biochim. Biophys. Acta 875 (1986) 610-617.
72. M. C. Lin, C. Arbeeny, K. Bergquist, B. Kienzle, D. A. Gordon, J. R. Wetterau: Cloning and regulation of hamster microsomal triglyceride transfer protein. The regulation is independent from that of other hepatic and intestinal proteins which participate in the transport of fatty acids and triglycerides. J. Biol. Chem. 269 (1994) 29138-29145.
73. D. L. Hagan, B. Kienzle, H. Jamil, N. Hariharan: Transcriptional regulation of human and hamster microsomal triglyceride transfer protein genes. Cell type-specific expression and response to metabolic regulators. J. Biol. Chem. 269 (1994) 28737-28744.
74. L. M. Powell, S. C. Wallis, R. J. Pease, Y. H. Edwards, T. J. Knott, J. Scoff: A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine. Cell 50 (1987) 831-840.
75. S. H. Chen, G. Habib, C. Y. Yang, Z. W. Gu, B. R. Lee, S. A. Weng, S. R. Silberman, S. J. Cai, J. P. Deslypere, M. Rosseneu, et al.: Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science 238 (1987) 363-366.
76. N. O. Davidson, M. J. Drewek, J. I. Gordon, J. Elovson: Rat intestinal apolipoprotein B gene expression. Evidence for integrated regulation by bile salt, fatty acid, and phospholipid flux. J. Clin. Invest. 82 (1988) 300-308.
77. N. O. Davidson, A. M. Magun, T. A. Brasitus, R. M. Glickman: Intestinal apolipoprotein A-I and B-48 metabolism: effects of sustained alterations in dietary triglyceride and mucosal cholesterol flux. J. Lipid Res. 28 (1987) 388-402.
78. M. Sorci-Thomas, M. D. Wilson, F. L. Johnson, D. L. Williams, L. L. Rudel: Studies on the expression of genes encoding apolipoproteins B100 and B48 and the low density lipoprotein receptor in nonhuman primates. Comparison of dietary fat and cholesterol. J. Biol. Chem. 264 (1989) 9039-9045.
79. F. Karpe: Postprandial lipoprotein metabolism and atherosclerosis. J. Intern. Med. 246 (1999) 341-355.
80. J. Auwerx, K. Schoonjans, J.C. Fruchart, B. Staels: Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR. Atherosclerosis 124 (1996) S29-S37.
81. Y. Andersson, Z. Majd, A. M. Lefebvre, G. Martin, A. V. Sechkin, V. Kosykh, J. C. Fruchart, J. Najib, B. Staels: Developmental and pharmacological regulation of apolipoprotein C-II gene expression. Comparison with apo C-I and apo C-III gene regulation. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 115-121.
82. P. Gervois, S. Chopin-Delannoy, A. Fadel, G. Dubois, V. Kosykh, J. C. Fruchart, J. Najib, V. Laudet, B. Staels: Fibrates increase human Rev-erbalpba expression in liver via a novel peroxisome proliferator-activated receptor response element. Mol. Endocrinol. 13 (1999) 400-409.
83. A. Mooney: Treating patients with hypertriglyceridaemia saves lives: triglyceride revisited. Curr. Med. Res. Opin. 15 (1999) 65-77.
84. C. Edelstein, C. Fredenrich, J. C. Schuelke, W. E. Jensen, M. Sitrin, P. H. Iverius, A. M. Scanu: Hypoalphalipoproteinemia: postprandial response of subjects with preprandial normotriglyceridemia and hypertriglyceridemia to various diets. Metabolism 42 (1993) 247-257.
85. K. Schoonjans, J. Peinado-Onsurbe, A. M. Lefebvre, R. A. Heyman, M. Briggs, S. Deeb, B. Staels, J. Auwerx: PPAR-alpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J. 15 (1996) 5336-5348.
86. E. Raspe, L. Madsen, A. M. Lefebvre, I. Leitersdorf, L. Gelrnan, J. Peinado-Onsurbe, J. Dallongeville, J. C. Fruchart, R. Berge, B. Staels: Modulation of rat liver apolipoprotein gene expression and serum lipid levels by tetradecylthioacetic acid (TTA) via PPARalpha activation. J. Lipid Res. 40 (1999) 2099-2110.
87. J. Rieusset, J. Auwerx, H. Vidal: Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes. Biochem. Biophys. Res. Commun. 265 (1999) 265-271.
88. W. Stremmel, G. Strohmeyer, F. Borchard, S. Kochwa, P. D. Berk: Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. Proc. Natl. Acad. Sci. USA 82 (1985) 4-8.
89. N. A. Abumrad, M. R. el-Maghrabi, E. Z. Amri, E. Lopez, P. A. Grimaldi: Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J. Biol. Chem. 268 (1993) 17665-17668.
90. J. E. Schaffer, H. F. Lodish: Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell 79 (1994) 427-436.
91. [91 ] D. Hirsch, A. Stahl, H. F. Lodish: A family of fatty acid transporters conserved from mycobacterium to man. Proc. Natl. Acad. Sci. USA 95 (1998) 8625-8629.
92. G. Martin, K. Schoonjans, B. Staels, J. Auwerx: PPARgamma activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes. Atherosclerosis 137 (1998) S75-S80.
93. K. A. van der Lee, M. M. Vork, J. E. De Vries, P. H. Willemsen, J. F. Glatz, R. S. Reneman, G. J. Van der Vusse, M. Van Bilsen: Long-chain fatty acid-induced changes in gene expression in neonatal cardiac myocytes J. Lipid Res. 41 (2000) 41-47.
94. S. Basu-Modak, O. Braissant, P. Escher, B. Desvergne, P. Honegger, W. Wahli: Peroxisome proliferator-activated receptor beta regulates acyl-CoA synthetase 2 in reaggregated rat brain cell cultures. J. Biol. Chem. 274 (1999) 35881-35888.
95. J. Berger, M. D. Leibowitz, T. W. Doebber, A. Elbrecht, B. Zhang, G. Zhou, C. Biswas, C. A. Cullinan, N. S. Hayes, Y. Li, M. Janen, J. Ventre, M. S. Wu, G. D. Berger, R. Mosley, R. Marquis, C. Santini, S. P. Sahoo, R. L. Tolman, R. G. Smith, D.E. Moller: Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects. J. Biol. Chem. 274 (1999) 6718-6725.
96. M. Elholm, G. Bjerking, J. Knudsen, K. Kristiansen, S. Mandrup: Regulatory elements in the promoter region of the rat gene encoding the acyl-CoA-binding protein. Gene 173 (1996) 233-238.
97. P. D. Pelton, L. Zhou, K. T. Demarest, T. P. Burns: PPARgamma activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes. Biochem. Biophys. Res. Commun. 261 (1999) 456-458.
98. A. V. Hertzel, D. A. Bernlohr: Regulation of adipocyte gene expression by polyunsaturated fatty acids. Mol. Cell. Biochem. 188 (1998) 33-39.
99. K. L. Houseknecht, J. P. Vanden Heuvel, S. Y. Moya-Camarena, C. P. Portocarrero, L. W. Peck, K. P. Nickel, M. A. Belury: Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat [published erratum appears in Biochem. Biophys. Res. Commun. 241 (1998) 911. Biochem. Biophys. Res. Commun. 244 (1998) 678-682.
100. T. C. Simon, K. A. Roth, J. I. Gordon: Use of transgenic mice to map cis-acting elements in the liver fatty acid-binding protein gene (Fabpl) that regulate its cell lineage-specific, differentiation-dependent, and spatial patterns of expression in the gut epithelium and in the liver acinus. J. Biol. Chem. 268 (1993) 18345-18358.
101. J. M. Brandt, F. Djouadi, D. P. Kelly: Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha. J. Biol. Chem. 273 (1998) 23786-23792.
102. C. Mascaro, E. Acosta, J. A. Ortiz, P. F. Marrero, F. G. Hegardt, D. Haro: Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. J. Biol. Chem. 273 (1998) 8560-8563.
103. T. Gulick, S. Cresci, T. Caira, D. D. Moore, D. P. Kelly: The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc. Natl. Acad. Sci. USA 91 (1994) 11012-11016.
104. T. Aoyama, J. M. Peters, N. Iritani, T. Nakajima, K. Furihata, T. Hashimoto, F. J. Gonzalez: Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J. Biol. Chem. 273 (1998) 5678-5684.
105. T. Hashimoto: Peroxisomal β-oxidation enzymes. Neurochem. Res. 24 (1999) 551-563.
106. J. D. Tugwood, I. Issemann, R. G. Anderson, K. R. Bundell, W. L. McPheat, S. Green: The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene. Embo J. 11 (1992) 433-439.
107. S. L. Marcus, K. S. Miyata, B. Zhang, S. Subramani, R. A. Rachubinski, J. P. Capons: Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferator-responsive elements of the rat hydratase/dehydrogenase and fatty acyl-CoA oxidase genes but differentially induce expression. Proc. Natl. Acad. Sci. USA 90 (1993) 5723-5727.
108. F. Caira, C. Pacot, O. Bardot, M. C. Malki, N. Lafruffe: Transcriptional and post-transcriptional analysis of peroxisomal protein encoding genes from rat treated with an hypolipemic agent, ciprofibrate. Effect of an intermittent treatment and influence of obesity. Biochem. Pharmacol. 49 (1995) 611-619.
109. C. Qi, Y. Zhu, J. Pan, N. Usuda, N. Maeda, A. V. Yeldandi, M. S. Rao, T. Hashimoto, J. K. Reddy: Absence of spontaneous peroxisome proliferation in enoyl-CoA hydratase/L-3-hydroxyacyl-CoA dehydrogenase-deficient mouse liver. Further support for the role of fatty acyl CoA oxidase in PPARalpha ligand metabolism. J. Biol. Chem. 274 (1999) 15775-15780.
110. R. Chu, Y. Lin, M. S. Rao, J. K. Reddy: Cooperative formation of higher order peroxisome proliferator-activated receptor and retinoid X receptor complexes on the peroxisome proliferator responsive element of the rat hydratasedehydrogenase gene. J. Biol. Chem. 270 (1995) 29636-29639.
111. N. Latruffe, V. Nicolas-Frances, V. K. Dasari, T. Osumi: Studies on regulation of the peroxisomal beta-oxidation at the 3-ketothiolase step. Dissection of the rat liver thiolase B gene promoter. Adv. Exp. Med. Biol. 466 (1999) 253-259.
112. M. A. Belury, S. Y. Moya-Camarena, H. Sun, E. Snyder, J. W. Davis, M. L. Cunningham, J. P. Vanden Heuvel: Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver. Toxicol. Appl. Pharmacol. 151 (1998) 254-261.
113. P. A. Watkins, W. W. Chen, C. J. Harris, G. Hoefler, S. Hoefler, D. C. Blake, Jr., A. Balfe, R. I. Kelley, A.B. Moser, M. E. Beard, et al.: Peroxisomal bifunctional enzyme deficiency. J. Clin. Invest. 83 (1989) 771-777.
114. F. S. Wouters, P. I. Bastiaens, K. W. A. Wirtz, T. M. Jovin: FRET microscopy demonstrates molecular association of non-specific lipid transfer protein (nsLTP) with fatty acid oxidation enzymes in peroxisomes. EMBO J. 17 (1998) 7179-7189.
115. U. Seedorf, M. Raabe, P. Ellinghaus, F. Kannenberg, M. Fobker, T. Engel, S. Denis, F. Wouters, K. W. Wirtz, R. J. Wanders, N. Maeda, G. Assmann: Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function. Genes Dev. 12 (1998) 1189-1201.
116. J. L. Hakaas, K. S. Gajiwala, M. Maffei, S. L. Cohen, B. T. Chait, D. Rabinowitz, R. L. Lallone, S. K. Burley, J. M. Friedman: Weight-reducing effects of the plasma protein encoded by obese gene. Science 269 (1995) 543-546.
117. L. J. Kelly, P. P. Vicario, G. M. Thompson, M. R. Candelore, T. W. Doebber, J. Ventre, M. S. Wu, R. Meurer, M. J. Forrest, M. W. Conner, M. A. Cascieri, D.E. Moller: Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression. Endocrinology 139 (1998) 4920-4927.
118. G. S. Hotamisligil, R. S. Johnson, R. J. Distel, R. Ellis, V. E. Papaioannou, B. M. Spiegelman: Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274 (1996) 1377-1379.
119. C. A. Jepson, S. J. Yeaman: Inhibition of hormone-sensitive lipase by intermediary lipid metabolites. FEBS Lett. 310 (1992) 197-200.
120. D. L. Severson, M. Hee-Cheong: Monoacylglycerol lipase activity in cardiac myocytes. Biochem. Cell Biol. 66 (1988) 1013-1018.
121. P. Tontonoz, E. Hu, B. M. Spiegelman: Regulation of adipocyte gene expression and differentiation by peroxi-some proliferator activated receptor gamma. Curr. Opin. Genet. Dev. 5 (1995) 571-576.
122. E. Z. Amri, G. Ailhaud, P. A. Grimaldi: Fatty acids as signal transducing molecules: involvement in the differentiation of preadipose to adipose cells. J. Lipid Res. 35 (1994) 930-937.
123. B. B. Lowell: PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function. Cell 99 (1999) 239-242.
124. K. H. Kim, H. J. Tae: Pattern and regulation of acetyl-CoA carboxylase gene expression. J. Nutr. 124 (1994) 1273S-1283S.
125. A. K. Joshi, S. Smith: Construction, expression, and characterization of a mutated animal fatty acid synthase deficient in the dehydrase function. J. Biol. Chem. 268 (1993) 22508-22513.
126. M. K. Mater, A. P. Thelen, D. A. Pan, D. B. Jump: Sterol response element-binding protein 1c (SREBP1c) is involved in the polyunsaturated fatty acid suppression of hepatic S14 gene transcription. J. Biol. Chem. 274 (1999) 32725-32732.
127. T. S. Worgall, S. L. Sturley, T. Seo, T. F. Osborne, R. J. Deckelbaum: Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of mature sterol regulatory element-binding protein. J. Biol. Chem. 273 (1998) 25537-25540.
128. S. D. Clarke, M. Turini, D. B. Jump, S. Abraham, M. Reedy: Polyunsaturated fatty acid inhibition of fatty acid synthase transcription is independent of PPAR activation. Z. Ernährungswiss. 37 (1998) 14-20.
129. A. M. Sessler, N. Kaur, J. P. Palta, J. M. Ntambi: Regulation of stearoyl-CoA desaturase 1 mRNA stability by polyunsaturated fatty acids in 3T3-L1 adipocytes. J. Biol. Chem. 271 (1996) 29854-29858.
130. K. M. Waters, C. W. Miller, J. M. Ntambi: Localization of a polyunsaturated fatty acid response region in stearoyl-CoA desaturase gene 1. Biochim. Biophys. Acta 1349 (1997) 33-42.
131. B. Staels, W. Koenig, A. Habib, R. Merval, M. Lebret, I. P. Torra, P. Delerive, A. Fadel, G. Chinetti, J. C. Fruchart, J. Najib, J. Maclouf, A. Tedgui: Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature 393 (1998) 790-793.
132. A. Bonazzi, V. Mastyugin, P. A. Mieyal, M. W. Dunn, M. Laniado-Schwartzman: Regulation of cyclooxygenase-2 by hypoxia and peroxisome proliferators in the corneal epithelium. J. Biol. Chem. 275 (2000) 2837-2844.
133. J. T. Huang, J. S. Welch, M. Ricote, C. J. Binder, T. M. Willson, C. Kelly, J. L. Witztum, C. D. Funk, D. Conrad, C. K. Glass: Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature 400 (1999) 378-382.
134. G. K. Balendiran, F. Schnutgen, G. Scapin, T. Borchers, N. Xhong, K. Lim, R. Godbout, F. Spener, J. C. Sacchettini: Crystal structure and thermodynamic analysis of human brain fatty acid-binding protein. J Biol Chem 275 (2000) 27045-54.
135. N. Guex, M. C. Peitsch: SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modelling. Electrophoresis 18 (1997) 2714-2723.
136. M. C. Peitsch: Protein modeling by E-mail. Bio/Technology 13 (1995) 658-660.
137. M. C. Peitsch: ProMod and Swiss-Model: Internet-based tools for automated comparative protein modelling. Biochem. Soc. Trans. 24 (1996) 274-279.
138. C. Hohoff, T. Börchers, B. Rüstow, F. Spener, H. van Tilbeurgh: Expression, purification, and crystal structure determination of recombinant human epidermal-type fatty acid binding protein. Biochemistry 38 (1999) 12229-12239.